ResearcherFirst Affiliated Hospital of GuangXi Medical UniversityNo recent work listed
Dianzhong Luo
Matched on OpenAlex author ID A5110329299. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper
Papers 4
- MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1. Co-author DOI 10.2147/cmar.s199257↗
- Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000494468↗
- Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomin… Last author DOI 10.2147/ott.s136878↗
- Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Last author DOI 10.7314/apjcp.2014.15.7.2971↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dan‐Ming Wei · 3 shared papers, 2017–2019 · strength 0.26
- Paper MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1. DOI 10.2147/cmar.s199257↗
- Paper Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000494468↗
- Paper Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive s… DOI 10.2147/ott.s136878↗
- Gang Chen · 3 shared papers, 2014–2019 · strength 0.24
- Paper MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1. DOI 10.2147/cmar.s199257↗
- Paper Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000494468↗
- Paper Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. DOI 10.7314/apjcp.2014.15.7.2971↗
- Jianghua Liu · 2 shared papers, 2014–2017 · strength 0.13
- Zhimin Chen · 1 shared paper, 2019 · strength 0.11
- Zucheng Xie · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.